US Patent Issued to ALVIT LCS PHARMA on Oct. 28 for "Fixed dose combination of cannabinoids and medical mushrooms for prevention and treatment of cancer, inflammatory or immune-mediated inflammatory diseases" (Israeli Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,453,750, issued on Oct. 28, was assigned to ALVIT LCS PHARMA LTD. (Tel Aviv, Israel).

"Fixed dose combination of cannabinoids and medical mushrooms for prevention and treatment of cancer, inflammatory or immune-mediated inflammatory diseases" was invented by Itschak Lamensdorf (Ness Ziona, Israel) and Yona Levy (Jerusalem).

According to the abstract* released by the U.S. Patent & Trademark Office: "A composition useful for treating immune-mediated inflammatory diseases or cancer in mammalian subjects is disclosed. The composition comprises a synergistic combination of a cannabis derived compound, and a medicinal mushroom."

The patent was filed on March 20, 2020, under Application No...